drugset / Trial / NCT01704196

A Multi-Center Trial of Nepicastat for Cocaine Dependence

NCT01704196

Phase 2 Completed 179 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.

Timeline

Start
2013-04
Primary completion
2014-08
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nepicastat Small molecule 120 mg
Comparator Riboflavin Other / unclassified 100 mg

Indications